Krishnan Suma (CIK 1298711) reported 85 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-05). Recent activity: Sell KRYS (320 shares), Sell KRYS (593 shares), Sell KRYS (247 shares), Sell KRYS (400 shares), Sell KRYS (480 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-05 | Krystal Biotech, Inc. (KRYS) | President, R&D | Sell | 320 | $96,240 |
| 2026-06-05 | Krystal Biotech, Inc. (KRYS) | President, R&D | Sell | 593 | $179,235 |
| 2026-06-05 | Krystal Biotech, Inc. (KRYS) | President, R&D | Sell | 247 | $74,883 |
| 2026-06-05 | Krystal Biotech, Inc. (KRYS) | President, R&D | Sell | 400 | $121,958 |
| 2026-06-05 | Krystal Biotech, Inc. (KRYS) | President, R&D | Sell | 480 | $146,815 |
| 2026-06-05 | Krystal Biotech, Inc. (KRYS) | President, R&D | Sell | 1,348 | $413,964 |
| 2026-06-05 | Krystal Biotech, Inc. (KRYS) | President, R&D | Sell | 12,729 | $3.9M |
| 2026-06-05 | Krystal Biotech, Inc. (KRYS) | President, R&D | Sell | 3,803 | $1.2M |
| 2026-06-05 | Krystal Biotech, Inc. (KRYS) | President, R&D | Sell | 2,801 | $868,156 |
| 2026-06-05 | Krystal Biotech, Inc. (KRYS) | President, R&D | Sell | 2,039 | $634,001 |
| 2026-06-05 | Krystal Biotech, Inc. (KRYS) | President, R&D | Sell | 240 | $74,796 |
| 2026-03-06 | Krystal Biotech, Inc. (KRYS) | President, R&D | Sell | 589 | $152,280 |
| 2026-03-06 | Krystal Biotech, Inc. (KRYS) | President, R&D | Sell | 407 | $104,729 |
| 2026-03-06 | Krystal Biotech, Inc. (KRYS) | President, R&D | Sell | 668 | $173,419 |
| 2026-03-06 | Krystal Biotech, Inc. (KRYS) | President, R&D | Sell | 3,667 | $954,777 |
| 2026-03-06 | Krystal Biotech, Inc. (KRYS) | President, R&D | Sell | 2,931 | $766,193 |
| 2026-03-06 | Krystal Biotech, Inc. (KRYS) | President, R&D | Sell | 1,938 | $508,434 |
| 2026-03-06 | Krystal Biotech, Inc. (KRYS) | President, R&D | Sell | 2,248 | $592,528 |
| 2026-03-06 | Krystal Biotech, Inc. (KRYS) | President, R&D | Sell | 4,852 | $1.3M |
| 2026-03-06 | Krystal Biotech, Inc. (KRYS) | President, R&D | Sell | 6,000 | $1.6M |
| 2026-03-06 | Krystal Biotech, Inc. (KRYS) | President, R&D | Sell | 1,700 | $452,914 |
| 2026-03-03 | Krystal Biotech, Inc. (KRYS) | President, R&D | Buy | 22,500 | $0 |
| 2026-03-03 | Krystal Biotech, Inc. (KRYS) | President, R&D | Sell | 10,236 | $2.8M |
| 2026-03-03 | Krystal Biotech, Inc. (KRYS) | President, R&D | Buy | 4,000 | $0 |
| 2026-03-03 | Krystal Biotech, Inc. (KRYS) | President, R&D | Sell | 1,820 | $501,665 |
Source: SEC Form 4 filings · as of 2026-06-05